The estimated Net Worth of William Hewitt Robinson is at least 1.35 百万$ dollars as of 15 March 2021. William Robinson owns over 5,000 units of Atreca Inc stock worth over 33,205$ and over the last 5 years William sold BCEL stock worth over 1,316,727$.
Sign up
William Robinson BCEL stock SEC Form 4 insiders trading
William has made over 17 trades of the Atreca Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently William sold 5,000 units of BCEL stock worth 84,450$ on 15 March 2021.
The largest trade William's ever made was selling 10,313 units of Atreca Inc stock on 19 June 2020 worth over 206,569$. On average, William trades about 3,436 units every 15 days since 2019. As of 15 March 2021 William still owns at least 368,948 units of Atreca Inc stock.
You can see the complete history of William Robinson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's William Robinson's mailing address?
William's mailing address filed with the SEC is C/O ATRECA, INC., 835 INDUSTRIAL RD., SUITE 400, SAN CARLOS, CA, 94070.
Insiders trading at Atreca Inc
Over the last 5 years, insiders at Atreca Inc have traded over 4,571,843$ worth of Atreca Inc stock and bought 6,001 units worth 76,740$ . The most active insiders traders include Group, Llc Green Jeremy Red...、Bros. Advisors Lp Baker Bro...、Harbor Master Investors (Ca.... On average, Atreca Inc executives and independent directors trade stock every 20 days with the average trade being worth of 991$. The most recent stock trade was executed by John A Orwin on 11 April 2024, trading 1 units of BCEL stock currently worth 0$.
What does Atreca Inc do?
atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. if you are interested in becoming part of the atreca team, our open positions can be found at: http://www.atreca.com/careers/
What does Atreca Inc's logo look like?
Complete history of William Robinson stock trades at Atreca Inc
Atreca Inc executives and stock owners
Atreca Inc executives and other stock owners filed with the SEC include:
-
John A. Orwin,
Pres, CEO & Director -
Herbert C. Cross,
Chief Financial Officer -
Dr. Stephen Gould Ph.D.,
Chief Scientific Officer -
Dr. Jonathan Benjamin M.D., Ph.D.,
Sr. VP of Clinical Research -
Dr. Daniel Emerling,
Sr. VP of Research -
Courtney J. Phillips J.D.,
Gen. Counsel & Corp. Sec. -
Dr. Yann Chong Tan,
Chief Technologist -
Dr. Tito A. Serafini Ph.D.,
Founder, Chief Strategy Officer & Director -
Bros. Advisors Lpbaker Juli...,
-
Kristine M Ball,
Director -
David L. Lacey,
Director -
Philippe C Bishop,
Chief Medical Officer -
Tito Serafini,
-
Franklin M Berger,
Director -
Brian G Atwood,
Director -
Lawrence Steinman,
Director -
William Hewitt Robinson,
Director -
& Melinda Gates Foundation ...,
-
Group, Llc Green Jeremy Red...,
-
Harbor Master Investors (Ca...,
10% owner -
Bros. Advisors Lp Baker Bro...,
-
Guy Cavet,
Chief Technical Officer -
Norman Michael Greenberg,
Chief Scientific Officer -
Lindsey Rolfe,
Director -
Herb Cross,
Chief Financial Officer -
Lisa Lynn Decker,
Chief Business Officer -
Stacey Ma,
Director -
Stephen R Brady,
Director -
Stephen E Gould,
Chief Scientific Officer -
Phillips Courtney,
GENERAL COUNSEL & SECRETARY -
John A Orwin,
PRESIDENT & CEO